Iswariya Venkataraman

Iswariya Venkataraman, PhD has a diverse work experience in scientific affairs and research. From 2018 to the present, they have been with EUROIMMUN US, starting as the Scientific Affairs Manager and then progressing to the roles of Associate Director and currently Director of Scientific Affairs. Prior to this, from 2014 to 2018, Iswariya worked as a Research Scientist at EUROIMMUN Medizinische Labordiagnostika AG. In 2010, they joined Thomson Reuters as a Research Analyst, where they gained experience in scientific writing and publishing research articles in various fields, including diabetes, hypertension, osteoporosis, rhinitis, and asthma. Iswariya's clients at Thomson Reuters included major pharma companies like Merck and Pfizer.

Iswariya Venkataraman, PhD completed their education in a chronological order as follows:

From 2005 to 2008, they attended Manipal Academy of Higher Education where they earned a Bachelor's degree in Biotechnology.

Following that, from 2008 to 2010, they pursued a Master's degree in Medical Biotechnology at Manipal Academy of Higher Education.

Lastly, from 2014 to 2018, they obtained a Doctor of Philosophy - PhD in Immunology from Universität zu Lübeck.